Senators demand more from GlaxoSmithKline to boost Shingrix supply

Senators demand more from GlaxoSmithKline to boost Shingrix supply

Source: 
Fierce Pharma
snippet: 

Amid high demand for GlaxoSmithKline's new shingles vaccine, healthcare providers are running out. Even though the company worked up what it calls a "fair and equitable" process to ship Shingrix doses, two U.S. senators are not satisfied and are urging the drugmaker do more to boost inventory levels.